21.03.2018 • News
Bayer
08.03.2018 • News
Covestro to Join Blue-chip Stock Index
07.03.2018 • News
BASF may buy Bayer's Vegetable Seeds
04.03.2018 • News
EFSA Finds Neonics to Harm Bees
07.02.2018 • News
Bayer Pledges More Concessions on Monsanto
30.01.2018 • News
EU Extends Bayer-Monsanto Deadline
19.01.2018 • News
FDA Confirms Xarelto Safety Profile
11.01.2018 • News
Bayer Divests More of Covestro
20.12.2017 • News
EU may seek more Bayer-Monsanto Concessions
13.12.2017 • News
Bayer Combines Pharma R&D in one Unit
12.12.2017 • News
First Loss for Bayer and J&J in Xarelto Suits
The German Capital Region
The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500 companies in the pharma, the biotech and the medtech industry.
21.11.2017 • News
Novartis and Bayer Warn on NHS Eye Drug Plan
10.11.2017 • News
EU’s Glyphosate Vote Fails Yet Again
26.10.2017 • News
EU Vote on Glyphosate Fails Yet Again
09.10.2017 • News
Bayer Cedes Control of Covestro
28.09.2017 • News
Bayer and Ginkgo Bioworks Start new Company
22.09.2017 • News
Bayer Details Agrochems Outlook and Plans
18.09.2017 • News
Wolfgang Nickl Appointed new CFO at Bayer
13.09.2017 • News
Bayer Cuts Covestro Shareholding Further
11.09.2017 • News
Bayer-Monsanto Deal may be Delayed
23.08.2017 • News
EU Starts In-Depth Probe of Bayer-Monsanto
22.08.2017 • News
Monsanto Licenses ToolGen’s CRISPR Technology
22.08.2017 • News
Bayer and J&J Win Third Xarelto Case
20.07.2017 • News
US States Restrict Monsanto’s Dicamba
06.07.2017 • News
Bayer Faces Profit Drain on Several Fronts
29.06.2017 • News
Bayer and Sumitomo in Fungicides Collaboration
29.06.2017 • News
Syngenta Eyes Seeds Assets, ChemChina may Float
22.06.2017 • News
Bayer Says EU Talks over Monsanto “Constructive”
